Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies.
Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies. It aims to find valuable solutions for medical needs by creating superior drug products. Both new and existing drugs can be combined with Cristal Therapeutics Polymeric Technologies, shortly abbreviated as CriPec. CriPec-based products are versatile as a crystal and allow to improve the treatment of various diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 19, 2017 | Series Unknown | €12.80M | 2 | — | — | Detail |
Dec 15, 2014 | Series Unknown | €6M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Utrecht University Holding and Management Innovation Fund | — | Series Unknown |
Nedermaas Hightech Ventures | — | Series Unknown |